Medexus Pharmaceuticals reports Q4 results
Seeking Alpha ·
Medexus Pharmaceuticals press release ( MEDXF ): Q4 Revenue of $24.7M (-0.4% Y/Y) misses by $0.53M . Historical earnings data for Medexus Pharmaceuticals Inc. Financial information for Medexus Pharmaceuticals Inc.
DYAX Investor Sentiment
Bullish (Long) 68% · Bearish (Short) 32%
441 participants
Related News
- Quantum anticipates $75M +/- $2M Q1 revenue amid $45M backlog and no outstanding debt
- Why Qualcomm (QCOM) Stock Is Up Today
- SpaceX Just Created an $82 Billion Opportunity -- and No One Is Talking About It
- Micron's Blowout Earnings Could Be Great News for Nvidia Investors
- RTX secures $1.11B contract modification for AIM-9X missile production.& delivery
- Balfour Beatty among winners of $8B U.S. Defense infrastructure multiple-award contract